NewsRamp Science, Exploration and Discovery Podcast
Subscribed: 1Played: 1
Subscribe
Description
Explore the wonders of science with the 'NewsRamp Science Podcast.' Each episode offers the latest news and detailed summaries from NewsRamp.com, covering scientific breakthroughs, research advancements, and technological innovations. Stay informed on the discoveries that shape our understanding of the world.
186 Episodes
Reverse
GeoVax Labs, Inc. reports positive interim results for its COVID-19 vaccine, Dr. Berenika Maciejewicz presents groundbreaking research on consciousness, and Kairos Pharma Ltd. will discuss interim efficacy results for ENV105 in advanced prostate cancer during a key opinion leader event. Exciting developments in healthcare and scientific advancements are shaping the future of medicine.
Sigyn Therapeutics, Inc. appoints Dr. Christoph Zaba to its Scientific Advisory Board, focusing on reducing cardiovascular disease risks through Sigyn Therapy™. Meanwhile, FORTA opens the Grand Rapids Testing Lab, dedicated to testing asphalt and concrete fibers to enhance infrastructure durability and innovation.
Aston Bay Holdings Ltd. announced promising findings from the MMT geophysical survey conducted at the Storm Copper Project on Somerset Island, Nunavut. The survey identified large conductive anomalies indicating potential high-grade zones at the Cyclone Deposit, hinting at copper sulphide mineralization. CEO Thomas Ullrich highlighted progress in permitting, economic studies, and feasibility work to move Storm towards a potential mining operation, positioning the project to capitalize on the growing demand for copper driven by electrification, renewable energy, and infrastructure development. Aston Bay focuses on exploring high-grade critical and precious metal deposits in North America, with ongoing exploration activities at the Storm Copper Property and Cu-Ag-Zn-Co Epworth Property in Nunavut.
VolitionRx Ltd. partners with Werfen to assess antiphospholipid syndrome, Soligenix Inc. showcases rare disease and public health pipeline, Trilogy Metals Inc. discusses mineral projects with South32, and G Mining Ventures Corp. announces high-grade discoveries at Oko West and progress at Gurupi.
Easy Environmental Solutions Inc. receives a deposit to deploy a microbial fertilizer system in Africa, Golden Cariboo Resources Ltd. confirms a new mineralized zone at the Quesnelle Gold Quartz Mine property, Renaissance BioScience Corp. secures funding for RNA interference technology to protect canola crops, and GeoVax Labs, Inc. will present data on a COVID-19 vaccine. Additionally, DCS Rescue sheds light on technical rescue operations, and Hypertension research highlights the need for accurate blood pressure measurement visuals.
Research presented at the American Heart Association's Hypertension Scientific Sessions 2025 highlights the effectiveness of AI voice agents in improving blood pressure monitoring for older adults, leading to better patient outcomes. Additionally, a study reveals that children with higher blood pressure at age 7 have an increased risk of early cardiovascular death, emphasizing the importance of monitoring blood pressure in childhood for long-term health.
The FigHTN Phase 2 clinical trial revealed that baxdrostat, an aldosterone production inhibitor, reduced systolic blood pressure by 5% and decreased urine albumin loss by 55% in individuals with chronic kidney disease and uncontrolled hypertension. These findings suggest baxdrostat's potential to delay kidney disease progression and improve long-term health outcomes, offering a promising solution for this at-risk population.
Registration and paper submissions are open for the 2025 World Young Scientist Summit (WYSS) in Wenzhou, China. The summit, themed 'Embracing Change: Young Scientists Shaping the Future Together,' will focus on the UN 2030 Sustainable Development Goals and feature sessions on youth development, sustainable development, technological innovation, and international collaboration. WYSS aims to empower young scientists, promote cooperation, and advance socio-economic progress through scientific and technological innovation.
Trilogy Metals Inc. is progressing high-grade mineral projects in Alaska, positioning itself as a key developer in North America's critical minerals sector. LaFleur Minerals Inc. is focusing on gold exploration in Québec, with a significant potential in the Abitibi Greenstone Belt, amidst record-high gold prices.
Recent studies presented at the American Heart Association’s Hypertension Scientific Sessions 2025 highlight the underutilization of salt substitutes in managing high blood pressure and the concerning rise in death rates from hypertensive kidney disease, particularly among certain demographic groups. Additionally, advancements in the field of biopharmaceuticals show promise in developing treatments for conditions like Parkinson's disease and multiple sclerosis, offering hope for improved outcomes.
Renaissance BioScience Corp. has obtained an Australian patent for their yeast-based platform technology, enabling cost-effective RNA production and delivery. This innovative technology is focused on RNAi-based biopesticides, offering precise pest control methods with enhanced environmental safety. Beyond agriculture, the technology also shows promise in animal health and human medicine, addressing challenges in RNA production across multiple industries.
Foremost Clean Energy Ltd. is issuing common shares to Denison Mines Corp., increasing Denison's ownership stake. Meanwhile, Kairos Pharma Ltd. will be presenting Phase 1 data on ENV105 at the World Lung Cancer Conference, focusing on its combination therapy with osimertinib to overcome drug resistance in cancer treatments.
InFlectis BioScience and Aix Marseille Université show promise in treating axonal forms of Charcot-Marie-Tooth Disease with IFB-088, seeking partnerships for clinical trials. Norsemont Mining Inc. secures funds for drilling at the Choquelimpie project, aiming to unlock its potential. Sigyn Therapeutics, Inc. plans a clinical study for Sigyn Therapy™ in high-risk cardiovascular disease subjects. Giant Mining Corp. launches Phase 2 Exploration Program at the Majuba Hill project in Nevada, leveraging AI technology to tap into the region's copper potential.
Foremost Clean Energy launches a drill program in Saskatchewan, Soligenix Inc. presents at an investment conference, Lahontan Gold Corp. reports positive drilling results in Nevada, and a study links head injuries to brain cancer risk, while McEwen Inc. announces high-grade drilling results at the Grey Fox Project.
IntegrateRNA offers Aminoacyl-tRNA In Vitro Synthesis Service for customizable tRNAs crucial in protein synthesis, while CD BioGlyco introduces Custom Glycoconjugate Synthesis for connecting glycans to proteins, lipids, or other molecules to study cell interactions and immune responses.
Alfa Chemistry now offers advanced diamond materials catering to industries like semiconductor production and biomedical research, providing precise control over abrasive removal rates and surface finish. Meanwhile, Creative Biolabs is driving the future of biopharmaceuticals through customized glycoprotein engineering services and in-depth carbohydrate analysis techniques, transforming molecular complexity into therapeutic clarity.
Zevra Therapeutics presents new data on MIPLYFFA targeting Niemann-Pick disease type C at a congress, while Clene Inc. focuses on neurodegenerative diseases with lead candidate CNM-Au8® for ALS, gearing up for a Phase 3 trial and having a late-stage MS program. Both companies offer innovative approaches to treating rare diseases with significant investment potential.
The use of PREVENT™ equations recommended in the AHA/ACC High Blood Pressure Guideline offers a more accurate risk assessment for cardiovascular disease in adults with hypertension, allowing for personalized treatment plans. Additionally, New Pacific Metals Corp. is exploring Bolivia's silver potential, while a study reveals a link between IBD and blood clot development, offering hope for improved treatment options.
MyBioSource has introduced a Sheep anti-Rat Calretinin Polyclonal antibody to their collection, targeting the vital calretinin protein involved in neurobiology and cellular calcium signaling. This antibody, with 100% sequence homology, has potential cross-reactivity with mouse, human, and non-human primate calretinin, making it valuable for researchers in neurodegeneration, calcium signaling, and auditory neuroscience.
New Pacific Metals Corp. advances its Silver Sand project in Bolivia, Foremost Clean Energy Ltd. reveals positive radon survey results in Saskatchewan, ESGold Corp. transforms abandoned mine waste into profitable operations, and a joint research team uncovers a mechanism behind resistance to cancer immunotherapy related to nerve damage.
Comments
Download from Google Play
Download from App Store
United States